Abstract:High glucose concentration, which provides the chief driving force in peritoneal dialysis, has been considered to be an important initial factor that contributes to peritoneal thickening and fibrosis. Human peritoneal mesothelial cells (HPMCs) and the expansion of extracellular matrix (ECM) play important roles in the pathological process of peritoneal fibrosis. Peritoneal matrix accumulation is a characteristic of peritoneal fibrosis (PF). Continuous ambulatory peritoneal dialysis (CAPD) patients with upregulation of transforming growth factor-beta 1 (TGF-beta 1) in their drained effluent show an increased risk of PE Inhibition of TGF-beta 1 expression in human peritoneal mesothelial cells (HPMCs) may provide a potential treatment for PF. sc58236, a highly selective cyclooxygenase-2 (COX-2) inhibitor, reduces proteinuria and mRNA expression of TGF-beta 1 and collagen III and IV in the remnant kidney, but their effects on ECM turnover in HPMCs are unknown. The aims of this study were to investigate the effects of sc58236 on TGF-beta 1 expression and matrix production in HPMCs. HPMCs were cultured from human omentum by an enzyme digestion method. To examine the effect of sc58236 on TGF-beta 1 and ECM secretion, HPMC were incubated in medium F12 with high concentration Of D-glucose (4.25%) in the presence and absence of 20 M sc58236. The mRNA expression of COX-2, TGF-beta 1 and collagen I (Col 1) were determined by semi-quantification reverse transcription PCR (RT-PCR). Prostaglandin E2 (PGE2) concentration in the culture medium was measured by enzyme-linked immunosorbent assay (ELISA). The protein of TGF-beta 1 was determined by ELISA and the activity of TGF-beta 1 present in the conditioned media was measured using the mink lung epithelial cell (MLEC) growth inhibition assay. Proteins of COX-2 and Col were determined by Western blot. The results showed that primary cultures of HPMCs do express the mRNA for COX-2 and stimulation of these cells with 4.25% D-glucose induced a marked increase in COX-2 mRNA expression and protein. PGE2 expression was obviously upregulated with stimulation by 4.25% D-glucose. Addition of 20 M sc58236 significantly inhibited PGE2 release into the culture medium. mRNA expression and bioactive and total protein of TGF-beta 1 and Col I were significantly increased in HPMCs stimulated with 4.25% D-glucose compared to the control group with F12 media, which was reversed in the presence of sc58236 (20 mu M). An obvious decrease in TGF-beta 1 mRNA expression and bioactive and total protein were found in sc58236 treated groups compared to the group stimulated with 4.25% D-glucose. Exposure of HPMCs to sc58236 reduced Col I secretion. Sc58236 reduces the expression of TGF-beta 1 in HPMCs stimulated by 4.25% D-glucose and reduces ECM production through PGE2 production. These studies suggest that sc58236, a highly selective cyclooxygenase-2 (COX-2) inhibitor, may have a specific role in ameliorating the course of progressive peritoneal fibrosis under long-term peritoneal dialysis states. (C) 2006 International Federation for Cell Biology. Published by Elsevier Ltd. All rights reserved.

Influence of Huangqi on TGF-beta 1 Inducing Extracellular Matrix Secretion of Human Peritoneal Mesothelial Cell

[Effect of TGFbeta1 Antisense RNA Expression Vector on Synthesis and Secretion of Extracellular Matrix in Cultured Human Peritoneal Mesothelial Cells].

Effects of Short Hairpin RNAs on TGF-β1 Expression and Ultrastructure in HPMCs Induced by Peritoneal Dialysis Solution

Effect of TGF-β1 on Connective Tissue Growth Factor of Human Peritoneal Mesothelial Cells

Effect of MAPK Signal Transduction Pathways on Human Peritoneal Fibrosis

Effect of TGF-β1 Stimulation on the Smad Signal Transduction Pathway of Human Peritoneal Mesothelial Cells.

[Inhibitive Effect of Troglitazone on TGF-beta(1) and Fibronectin Expression in Human Peritoneal Mesothelial Cells].

Effect of TGFβ1 Antisense Oligodeoxynucleotides (ASON) Proliferation and Fibronectin Expression on Human Peritoneal Mesothelial Cell

Effects of Hirsutella Sinensis on the Expression of Transforming Growth Factor-β1 and Fibronectin in Rat Peritoneal Mesothelial Cells Cultured in High Glucose Concentration

[Effects of High Glucose on the Cell Proliferation, Damage and Cytokine in Human Peritoneal Mesothelial Cells].

Connective Tissue Growth Factor Knockdown Attenuated Matrix Protein Production and Vascular Endothelial Growth Factor Expression Induced by Transforming Growth Factor‐β1 in Cultured Human Peritoneal Mesothelial Cells

Astragalus Mongholicus Altered the Secretion and Expression of Transforming Growth Factor-Β1 and Basic Fibroblast Growth Factor in Cultured Human Peritoneal Mesothelial Cells

Inhibition of Transforming Growth Factor Beta (tgfbeta1) Expression and Extracellular Matrix Secretion in Human Peritoneal Mesothelial Cells by Pcdu6 Vector-Mediated TGFbeta1 Shrna and by Pcdna3.1(-)-mediated Antisense TGFbeta1 RNA.

Effect of High Glucose on the Expression of Fibronectin and Plasminogen Activator Inhibitor-1 in Human Peritoneal Mesothelial Cells

Inhibition Effect Of Small Interfering Rna Of Connective Tissue Growth Factor On The Expression Of Vascular Endothelial Growth Factor And Connective Tissue Growth Factor In Cultured Human Peritoneal Mesothelial Cells

The Effect of Tanshinone ⅡA on the Secretion and Expression of VEGF and TGF-β1 in Cultured Human Peritoneal Mesothelial Cells

A Selective Cyclooxygenase-2 Inhibitor Decreases Transforming Growth Factor-Beta 1 Synthesis and Matrix Production in Human Peritoneal Mesothelial Cells

Effect of Pentoxifylline on Human Peritoneal Mesothelial Cells' Function and TGF-β1, FN Secretion Induced by Lactate-buffered Peritoneal Dialysis Solutes

Effects of Astragalus on Secretion and Mrna Expression of TGF-β1 Induced by Peritoneal Dialysis Solution in Cultured Human Peritoneal Mesothelial Cell

Role of IGF-1R in Epithelial–mesenchymal Transdifferentiation of Human Peritoneal Mesothelial Cells

Troglitazone Inhibits Synthesis of Transforming Growth Factor-Beta1 and Reduces Matrix Production in Human Peritoneal Mesothelial Cells.